<DOC>
	<DOCNO>NCT01563471</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate pharmacokinetics three different single dos activate recombinant human factor VII Caucasian Japanese healthy subject .</brief_summary>
	<brief_title>Safety Tolerability Intravenous Doses Activated Recombinant Human Factor VII Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Caucasian Japanese Healthy define medical history , physical biological examination History allergy hypersensitivity reaction medication History presence organic disorder likely modify absorption , distribution elimination medication Alcohol substance abuse disorder Subject exclusion period Healthy Volunteers National Register French Ministry Health</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>